These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 21182786)
1. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Nguyen CQ; Yin H; Lee BH; Carcamo WC; Chiorini JA; Peck AB Arthritis Res Ther; 2010; 12(6):R220. PubMed ID: 21182786 [TBL] [Abstract][Full Text] [Related]
2. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer. Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230 [TBL] [Abstract][Full Text] [Related]
3. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome. Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922 [TBL] [Abstract][Full Text] [Related]
4. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793 [TBL] [Abstract][Full Text] [Related]
5. Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Lin X; Rui K; Deng J; Tian J; Wang X; Wang S; Ko KH; Jiao Z; Chan VS; Lau CS; Cao X; Lu L Ann Rheum Dis; 2015 Jun; 74(6):1302-10. PubMed ID: 24573745 [TBL] [Abstract][Full Text] [Related]
6. Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren's syndrome mice. Wanchoo A; Voigt A; Sukumaran S; Stewart CM; Bhattacharya I; Nguyen CQ Sci Rep; 2017 Oct; 7(1):12512. PubMed ID: 28970488 [TBL] [Abstract][Full Text] [Related]
7. Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models. Zhou J; Felix FA; Jiang Y; Li D; Kim MC; Jang D; Cha S; Yu Q Mol Immunol; 2024 Oct; 174():47-56. PubMed ID: 39197397 [TBL] [Abstract][Full Text] [Related]
8. IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Alunno A; Bistoni O; Bartoloni E; Caterbi S; Bigerna B; Tabarrini A; Mannucci R; Falini B; Gerli R Ann Rheum Dis; 2013 Feb; 72(2):286-92. PubMed ID: 22904262 [TBL] [Abstract][Full Text] [Related]
9. Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: Potential role of Th17•Th1 in the pathogenesis of autoimmune diseases. Nanke Y; Kobashigawa T; Yago T; Kawamoto M; Yamanaka H; Kotake S Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):473-477. PubMed ID: 27795505 [TBL] [Abstract][Full Text] [Related]
10. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Peck AB; Nguyen CQ; Ambrus J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Vosters JL; Landek-Salgado MA; Yin H; Swaim WD; Kimura H; Tak PP; Caturegli P; Chiorini JA Arthritis Rheum; 2009 Dec; 60(12):3633-41. PubMed ID: 19950301 [TBL] [Abstract][Full Text] [Related]
12. Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren's syndrome. Zhou YB; Yuan X; Wang QK; Zhang H; Wang GS; Li XP; Wang Y; Harris D; Li XM Immunol Lett; 2020 Oct; 226():62-70. PubMed ID: 32707129 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions. Zhou J; Jin JO; Patel ES; Yu Q Cytokine; 2015 Dec; 76(2):244-252. PubMed ID: 26255211 [TBL] [Abstract][Full Text] [Related]
14. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome. Benchabane S; Boudjelida A; Toumi R; Belguendouz H; Youinou P; Touil-Boukoffa C Int J Immunopathol Pharmacol; 2016 Sep; 29(3):386-97. PubMed ID: 27207443 [TBL] [Abstract][Full Text] [Related]
15. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice. Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells. Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724 [TBL] [Abstract][Full Text] [Related]
19. Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome. Fei Y; Zhang W; Lin D; Wu C; Li M; Zhao Y; Zeng X; Zhang F Clin Rheumatol; 2014 Apr; 33(4):523-9. PubMed ID: 24420723 [TBL] [Abstract][Full Text] [Related]
20. IL-17 and CCR9 Hwang SH; Woo JS; Moon J; Yang S; Park JS; Lee J; Choi J; Lee KH; Kwok SK; Park SH; Cho ML Front Immunol; 2021; 12():721453. PubMed ID: 34539657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]